Autoimmunity in 2009

Carlo Selmi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The number of 2009 publications in indexed journals dealing with 'autoimmunity' has maintained its increasing trend compared to the previous five years. Numerous developments have been proposed in our understanding of systemic and organ-specific autoimmune diseases (particularly multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis) and of basic autoimmunity mechanisms (particularly Th17, T regulatory cells, and autoantibodies). Both these lines of evidence share a significant potential to be translated into new therapeutic options to impact clinical practice. This article will discuss selected publications from prominent scientific journals dedicated to immunology and autoimmunity and ultimately include some expectations in branches of autoimmunity that appear promising for future developments.

Original languageEnglish (US)
Pages (from-to)795-800
Number of pages6
JournalAutoimmunity Reviews
Volume9
Issue number12
DOIs
StatePublished - Oct 2010

Fingerprint

Autoimmunity
Publications
Regulatory T-Lymphocytes
Allergy and Immunology
Systemic Lupus Erythematosus
Autoantibodies
Autoimmune Diseases
Multiple Sclerosis
Rheumatoid Arthritis
Therapeutics

Keywords

  • Immune tolerance
  • T regulatory cells
  • Th17
  • Traditional autoantigens

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy

Cite this

Autoimmunity in 2009. / Selmi, Carlo.

In: Autoimmunity Reviews, Vol. 9, No. 12, 10.2010, p. 795-800.

Research output: Contribution to journalArticle

Selmi, Carlo. / Autoimmunity in 2009. In: Autoimmunity Reviews. 2010 ; Vol. 9, No. 12. pp. 795-800.
@article{60d23c80c0704568b3f535cdf6fb7d77,
title = "Autoimmunity in 2009",
abstract = "The number of 2009 publications in indexed journals dealing with 'autoimmunity' has maintained its increasing trend compared to the previous five years. Numerous developments have been proposed in our understanding of systemic and organ-specific autoimmune diseases (particularly multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis) and of basic autoimmunity mechanisms (particularly Th17, T regulatory cells, and autoantibodies). Both these lines of evidence share a significant potential to be translated into new therapeutic options to impact clinical practice. This article will discuss selected publications from prominent scientific journals dedicated to immunology and autoimmunity and ultimately include some expectations in branches of autoimmunity that appear promising for future developments.",
keywords = "Immune tolerance, T regulatory cells, Th17, Traditional autoantigens",
author = "Carlo Selmi",
year = "2010",
month = "10",
doi = "10.1016/j.autrev.2010.08.008",
language = "English (US)",
volume = "9",
pages = "795--800",
journal = "Autoimmunity Reviews",
issn = "1568-9972",
publisher = "Elsevier",
number = "12",

}

TY - JOUR

T1 - Autoimmunity in 2009

AU - Selmi, Carlo

PY - 2010/10

Y1 - 2010/10

N2 - The number of 2009 publications in indexed journals dealing with 'autoimmunity' has maintained its increasing trend compared to the previous five years. Numerous developments have been proposed in our understanding of systemic and organ-specific autoimmune diseases (particularly multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis) and of basic autoimmunity mechanisms (particularly Th17, T regulatory cells, and autoantibodies). Both these lines of evidence share a significant potential to be translated into new therapeutic options to impact clinical practice. This article will discuss selected publications from prominent scientific journals dedicated to immunology and autoimmunity and ultimately include some expectations in branches of autoimmunity that appear promising for future developments.

AB - The number of 2009 publications in indexed journals dealing with 'autoimmunity' has maintained its increasing trend compared to the previous five years. Numerous developments have been proposed in our understanding of systemic and organ-specific autoimmune diseases (particularly multiple sclerosis, systemic lupus erythematosus, and rheumatoid arthritis) and of basic autoimmunity mechanisms (particularly Th17, T regulatory cells, and autoantibodies). Both these lines of evidence share a significant potential to be translated into new therapeutic options to impact clinical practice. This article will discuss selected publications from prominent scientific journals dedicated to immunology and autoimmunity and ultimately include some expectations in branches of autoimmunity that appear promising for future developments.

KW - Immune tolerance

KW - T regulatory cells

KW - Th17

KW - Traditional autoantigens

UR - http://www.scopus.com/inward/record.url?scp=77956895158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956895158&partnerID=8YFLogxK

U2 - 10.1016/j.autrev.2010.08.008

DO - 10.1016/j.autrev.2010.08.008

M3 - Article

VL - 9

SP - 795

EP - 800

JO - Autoimmunity Reviews

JF - Autoimmunity Reviews

SN - 1568-9972

IS - 12

ER -